Lantus median prices in select countries 2019

This statistic displays a comparison of median prices for Sanofi's pharmaceutical product Lantus (insulin glargine) in 2019. In that year, five syringes of Lantus cost 419 U.S. dollars in the U.S. while the same drug was available for 86 U.S. dollars in Switzerland.

Median prices of Lantus in select countries in 2019 (in U.S. dollarsl)

Characteristic	Median price in U.S. dollars
United States	419
United Arab Emirates	107
Switzerland	86
Germany	80
Chile	68
Spain	63
Greece	59
South Africa	55
Kazakhstan	52

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

July 2022

More information

Region

Worldwide, United States

Survey time period

2019

Supplementary notes

Prices are for Lantus (insulin glargine 3ml 100 IU), 5 syringes.
The source compared the median prices paid by a sample of private health insurance companies for 34 specific health care services in 11 countries in 2019. Health cost comparisons among various countries are complicated by differences in sectors, fee schedules, and prices may not be representative of prices paid by other plans in that market. The limitations were minimized by selecting services with very specific definitions and wording survey questions to match the procedures that are the basis of the U.S. payment system.

* Swiss costs are list prices prior to any discount payers may receive.

Citation formats